On 13 February 2020, Starpharma Holdings Limited (ASX: SPL) announced the launch of its product VivaGel® BV under the brand name of BETADINETM BV Gel in South East Asia region along with Mundipharma’s marketing and regulatory teams.
With this launch in Asia, the Company foresees a huge commercial opportunity of having access to nearly 1.5 billion women.
Asia being the third region to grant the permission of VivaGel® BV, the Company has plans to launch the product in other Mundipharma regions, subject to regulatory approvals.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.